Tetraphase Pharmaceuticals Story

Under 67% of Tetraphase Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in Tetraphase Pharmaceuticals suggests that many traders are alarmed regarding Tetraphase Pharmaceuticals' prospects. Tetraphase Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Tetraphase Pharmaceuticals. The current market sentiment, together with Tetraphase Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Tetraphase Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Tetraphase Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Tetraphase daily returns and investor perception about the current price of Tetraphase Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Tetraphase Pharmaceuticals.

Tetraphase Pharmaceuticals Latest Timeline

Tetraphase Pharmaceuticals is listed for 0.00. About 45.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.58. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tetraphase Pharmaceuticals recorded a loss per share of 13.31. The entity had not issued any dividends in recent years. The firm had a split on the 27th of September 2019.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in Tetraphase Stock

If you are still planning to invest in Tetraphase Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tetraphase Pharmaceuticals' history and understand the potential risks before investing.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Stocks Directory
Find actively traded stocks across global markets
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes